Arcutis Biotherapeutics Stock Forecast
Recent Arcutis Biotherapeutics Stock Price | Arcutis Biotherapeutics Stock Forecast Price | |
$8.59 | +92.08% |
$16.50 |
Recent Arcutis Biotherapeutics Analyst Ratings Breakdown | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 4 | 4 | 4 | 4 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.5 | 1.5 | 1.5 | 1.5 |
The presented Arcutis Biotherapeutics stock forecast (traded under symbol ARQT), for forward-twelve-months price target as shown at the top of this page, gives you the average Arcutis Biotherapeutics stock forecast for forward target price for symbol ARQT, across the 6 analysts covering Arcutis Biotherapeutics (ARQT), as reported in data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Arcutis Biotherapeutics stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Arcutis Biotherapeutics stock forecast and half had a lower Arcutis Biotherapeutics stock forecast) was $17.0 as of 2024-04-26 (which is a different mathematical metric versus taking the average or mean), while the
highest Arcutis Biotherapeutics stock forecast in the analyst group was $26.0, and the lowest Arcutis Biotherapeutics stock forecast in the analyst group was
$8.0, with a standard deviation of $6.442. Get the latest Zacks research report on ARQT — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
Free ARQT Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (3.50 out of 4) 59th percentile
(ranked higher than approx. 59% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |